0.3706

0.72% -0.0027

After Hours: .37 -0.0006 -0.16%

Co Diagnostics Inc (CODX)

Overview News Price History Option Chain Financials Discussions Forecast

Co Diagnostics Inc stock is traded at $0.3706, with a volume of 940.93K. It is down -0.72% in the last 24 hours and down -34.98% over the past month. Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Previous Close:

$0.3733

Open:

$0.3647

24h Volume:

940.93K

Relative Volume:

0.04

Market Cap:

$22.57M

Revenue:

$7.11M

Net Income/Loss:

$-41.28M

P/E Ratio:

-0.2686

EPS:

-1.38

Net Cash Flow:

$-26.84M

1W Performance:

+5.83%

1M Performance:

-34.98%

6M Performance:

+27.79%

1Y Performance:

-60.42%

1-Day Range:

$0.3626

$0.3921

1-Week Range:

$0.3201

$0.416

52-Week Range:

$0.2275

$1.55

Co Diagnostics Inc Stock (CODX) Company Profile

Name

Co Diagnostics Inc

Sector

Healthcare (1139)

Industry

Medical Devices (144)

Phone

(801) 278-9769

Address

4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY

Employee

132

Twitter

@Co_Diagnostics

Next Earnings Date

2024-11-07

Latest SEC Filings

CODX's Discussions on Twitter

Compare CODX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CODX Co Diagnostics Inc	0.3706	22.73M	7.11M	-41.28M	-26.84M	-1.38
ABT Abbott Laboratories	128.90	223.51B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	101.58	149.67B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	371.18	142.37B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	105.33	134.64B	34.76B	4.79B	5.21B	3.7017
EW Edwards Lifesciences Corp	86.67	50.34B	5.88B	1.34B	799.60M	2.3489

Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-12-22	Downgrade	Sidoti	Buy → Neutral
Dec-29-21	Initiated	Sidoti	Buy
Mar-29-21	Downgrade	Maxim Group	Buy → Hold
May-20-20	Upgrade	Maxim Group	Hold → Buy
May-18-20	Reiterated	H.C. Wainwright	Buy
Mar-09-20	Reiterated	H.C. Wainwright	Buy
Mar-03-20	Downgrade	Maxim Group	Buy → Hold

View All

Co Diagnostics Inc Stock (CODX) Latest News

Nov 27, 2025

Is Co Diagnostics Inc. a good long term investmentContrarian Investment Ideas & Build Wealth Brick by Brick With Us - earlytimes.in

Nov 27, 2025

Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results (PR Newswire) - Aktiellt

Nov 27, 2025

Nov 26, 2025

Maxim Group Initiates Coverage of Co-Diagnostics (CODX) with Buy Recommendation - Nasdaq

Nov 26, 2025

Co-Diagnostics (CODX) Initiated with 'Buy' Rating by Maxim Group - GuruFocus

Nov 26, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Nov 26, 2025

Nov 25, 2025

HC Wainwright & Co. Reiterates Co-Diagnostics (CODX) Neutral Recommendation - MSN

Nov 25, 2025

Nov 24, 2025

[Form 4] Co-Diagnostics, Inc. Insider Trading Activity - Stock Titan

Nov 24, 2025

Chmn Egan Surrenders 49,575 Of Co-Diagnostics Inc [CODX] - TradingView

Nov 24, 2025

HC Wainwright Reiterates Neutral Rating for Co-Diagnostics (CODX) | CODX Stock News - GuruFocus

Nov 24, 2025

Nov 21, 2025

Can Co Diagnostics Inc. stock hit analyst price targets2025 Risk Factors & Safe Capital Growth Trade Ideas - newser.com

Nov 21, 2025

Will Co Diagnostics Inc. stock attract ESG investorsEarnings Overview Report & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 21, 2025

Nov 20, 2025

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption - GuruFocus

Nov 20, 2025

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health - The Herald Journal

Nov 20, 2025

Developing predictive dashboards with Co Diagnostics Inc. dataDollar Strength & Fast Moving Stock Trade Plans - newser.com

Nov 20, 2025

Chart overlay techniques for tracking Co Diagnostics Inc.Earnings Recap Report & Daily Profit Maximizing Tips - newser.com

Nov 20, 2025

Co-Diagnostics (CODX) Q3 2025 Earnings Transcript - AOL.com

Nov 20, 2025

Nov 19, 2025

Predicting Co Diagnostics Inc. trend using moving averagesWeekly Loss Report & Safe Capital Growth Tips - newser.com

Nov 19, 2025

Why Co Diagnostics Inc. stock remains on buy listsJuly 2025 Price Swings & Reliable Breakout Stock Forecasts - newser.com

Nov 19, 2025

MSN Money - MSN

Nov 19, 2025

What technical models suggest about Co Diagnostics Inc.’s comebackTrade Volume Report & Weekly Setup with ROI Potential - newser.com

Nov 19, 2025

Nov 18, 2025

Will Co Diagnostics Inc. stock benefit from AI adoptionWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com

Nov 18, 2025

How sentiment analysis helps forecast Co Diagnostics Inc.2025 Technical Overview & Stepwise Trade Signal Implementation - newser.com

Nov 18, 2025

Co-Diagnostics Earnings Call: Strategic Moves Amid Financial Struggles - MSN

Nov 18, 2025

How Co Diagnostics Inc. stock trades during market volatilityWeekly Market Outlook & AI Powered Trade Plan Recommendations - newser.com

Nov 18, 2025